Five-Year PAP Persistence, Adherence and Patient Follow-up After Implementation of Telemonitoring and Pay-For-Performance in France

Abstract Rationale Following an important increase in the number of patients treated with positive airway pressure (PAP) therapy in France, a new nationwide model combining telemonitoring and a pay-for-performance scheme was implemented in 2018. Objectives To provide a comprehensive overview of 5-year persistence and adherence to PAP therapy and healthcare utilization after the change in the PAP pathway and model. Methods This real-world cohort included adults from France started on PAP in 2019–2023. Data sources included provider records (including daily PAP data) and national claims data. Costs were evaluated from the national payer perspective. Results A total of 84,550 patients (63.7% men, mean age 58.5 years, 53.6% with obesity, mean apnea-hypopnea index 40 events/h) were included; 95.7% used telemonitoring. 58,116 patients had paired claims data. PAP therapy persistence was 83.5% at 1 year, 68.4% at 3 years and 60.5% at 5 years. Main documented reasons for stopping PAP were issues with PAP treatment (54.9%), changes in treatment needs (9.3%) and death (7.0%). There was a dose-effect association between PAP adherence in the first 4 months and 5-year persistence. In the first year of treatment, on average, patients consulted with a general practitioner 6.66 times and with another medical specialist 2.53 times; over the same period home service providers delivered 4.0 interventions at home, 3.6 by phone and 2.8 masks. The number of provider interventions (logistic, educational and supportive) increased as adherence decreased. Mean yearly total cost per patient was €5,462: €1,526 (28%) for hospitalizations, €672 (12%) for disability pensions and sick leave benefits, €436 (8%) for the PAP device, consumables and service, and €415 (8%) for medical consultations. Conclusions The proportion of adherent patients at 5 years was high, partly driven by the early discontinuation of patients with low adherence. Alongside intensive medical follow-up, HSPs delivered interventions at greater intensity for patients with low adherence, consistent with the objective of the nationwide telemonitoring and pay-for-performance model. However, solutions are needed for patients who have PAP-related issues and to further reduce the therapy termination rate.

Authors

Institutions

Publication Details

Journal
Annals of the American Thoracic Society
Published
2026-11-14
DOI
https://doi.org/10.1093/annalsats/aaoag344
Primary Topic
Obstructive Sleep Apnea Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Five-Year PAP Persistence, Adherence and Patient Follow-up After Implementation of Telemonitoring and Pay-For-Performance in France

Clara Bianquis, Manuella Schaller, Sébastien Baillieul, Arnaud Prigent et al.
Annals of the American Thoracic Society
Obstructive Sleep Apnea Research
article

Five-Year PAP Persistence, Adherence and Patient Follow-up After Implementation of Telemonitoring and Pay-For-Performance in France

Clara Bianquis, Manuella Schaller, Sébastien Baillieul, Arnaud Prigent, Frédéric Gagnadoux, Sarah Alami, Joëlle Texereau, Fabienne Diaz Bazin
article en

Abstract

Abstract Rationale Following an important increase in the number of patients treated with positive airway pressure (PAP) therapy in France, a new nationwide model combining telemonitoring and a pay-for-performance scheme was implemented in 2018. Objectives To provide a comprehensive overview of 5-year persistence and adherence to PAP therapy and healthcare utilization after the change in the PAP pathway and model. Methods This real-world cohort included adults from France started on PAP in 2019–2023. Data sources included provider records (including daily PAP data) and national claims data. Costs were evaluated from the national payer perspective. Results A total of 84,550 patients (63.7% men, mean age 58.5 years, 53.6% with obesity, mean apnea-hypopnea index 40 events/h) were included; 95.7% used telemonitoring. 58,116 patients had paired claims data. PAP therapy persistence was 83.5% at 1 year, 68.4% at 3 years and 60.5% at 5 years. Main documented reasons for stopping PAP were issues with PAP treatment (54.9%), changes in treatment needs (9.3%) and death (7.0%). There was a dose-effect association between PAP adherence in the first 4 months and 5-year persistence. In the first year of treatment, on average, patients consulted with a general practitioner 6.66 times and with another medical specialist 2.53 times; over the same period home service providers delivered 4.0 interventions at home, 3.6 by phone and 2.8 masks. The number of provider interventions (logistic, educational and supportive) increased as adherence decreased. Mean yearly total cost per patient was €5,462: €1,526 (28%) for hospitalizations, €672 (12%) for disability pensions and sick leave benefits, €436 (8%) for the PAP device, consumables and service, and €415 (8%) for medical consultations. Conclusions The proportion of adherent patients at 5 years was high, partly driven by the early discontinuation of patients with low adherence. Alongside intensive medical follow-up, HSPs delivered interventions at greater intensity for patients with low adherence, consistent with the objective of the nationwide telemonitoring and pay-for-performance model. However, solutions are needed for patients who have PAP-related issues and to further reduce the therapy termination rate.

Annals of the American Thoracic Society
Inserm (FR), Air Liquide (United Kingdom) (GB), Centre Hospitalier Universitaire de Grenoble (FR), Sorbonne Université (FR), Hôpital Cochin (FR), Assistance Publique – Hôpitaux de Paris (FR), Saint Laurent Polyclinique (FR), Centre Hospitalier Universitaire d'Angers (FR), Université d'Angers (FR), Université Grenoble Alpes (FR)
Obstructive Sleep Apnea Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon